#AIEye
#Podcast 684: #Stocks discussed: (NYSE: $PATH) (NasdaqGM: $IPA) #artificialintelligence
UiPath Announces Strategic Partnership with NCS, and
IPA Completes Acquisition of BioStrand
Global
#AI in #Military Market to Reach $13.71B by 2028
Vancouver, Kelowna, Delta, BC – April 18, 2022 –
Investorideas.com, a global
investor news source covering Artificial Intelligence (AI) brings you today’s edition
of The
AI Eye-watching stock news, deal tracker and advancements in
artificial intelligence
Listen
to today’s podcast:
https://www.investorideas.com/Audio/Podcasts/2022/041822-AI-Eye.mp3
Read
this in full at https://www.investorideas.com/news/2022/artificial-intelligence/04181PATH-IPA.asp
Today’s
Column- The
AI Eye- Watching stock news, deal tracker and
advancements in artificial intelligence
Stocks
discussed: (NYSE:PATH) (NasdaqGM:IPA)
UiPath, Inc. (NYSE:PATH) has announced a strategic partnership with
technology services firm NCS for “the deployment of enterprise-grade automation
capabilities.” Howie Lau, Managing Partner of Corporate Development and
Partnerships, NCS, said:
"The
convergence of 5G, IoT, and artificial intelligence (AI) has created new
business opportunities for enterprises and consumers. To fully capitalize on
this, enterprises need to improve the performance, flexibility, and reliability
of their technology. NCS is investing in developing intelligent and automated
operating models to deliver rich customer experiences and drive high-impact
employee engagement. Through our partnership with UiPath, we are reimagining
and simplifying internal processes by integrating automation into our business
units and products to offer our clients more intelligent and elevated services
for the digital age."
ImmunoPrecise Antibodies, Ltd. (NasdaqGM:IPA) has completed its previously announced acquisition
of control over Belgian biotech entities BioStrand BV, BioKey BV, and BioClue
BV – henceforth to be collectively referred to as BioStrand. Jennifer Bath, CEO
of IPA, explained:
"Uniting
BioStrand and IPA reflects the Company’s commitment to acquiring truly
transformative technologies that leapfrog traditional competencies driving the
development of safe and effective antibody therapies. For several years IPA’s
team has scrutinized artificial intelligence (AI) and machine learning
technologies, in search of capabilities that don’t simply give a nod to an
opaque use of computationally-driven analyses, nor incremental and limited
additions to currently existing research tools, but instead change the
trajectory of personalized medicines and the philosophy behind what is truly
meaningful for the future of AI in the life sciences.”
Global
AI in Military Market to Reach $13.71B by 2028
A report published by Vantage Market Research finds that the global
AI in Military market is projected to grow from $6.62 billion USD in 2021 to
$13.71 billion by 2028, registering a compound annual growth rate (CAGR) of
12.9 percent in the forecast period 2022-28. An excerpt from the report’s description
outlines some factors influencing the growth of the market:
The
growth of Artificial Intelligence In Military sector is mainly attributed to
the growth in the development of Artificial Intelligence integrated systems and
the increasing adoption of cloud-based high-performance computers and
applications. Moreover, the increase in government initiatives and funding for
the defense sector in major countries to advance AI capabilities, and the
development of specialized AI chips in the market are projected to fuel the
growth of the Artificial Intelligence In Military market in the coming years.
Sam Mowers, Investorideas.com
Read and
hear other editions of the AI Eye
For a list of
artificial intelligence stocks on Investorideas.com visit
here
About Investorideas.com -
News that Inspires Big Investing Ideas
Investorideas.com
publishes breaking stock news, third party stock research, guest posts and
original articles and podcasts in leading stock sectors. Learn about investing in stocks and get
investor ideas in cannabis, crypto, AI and IoT, mining, sports biotech, water,
renewable energy, gaming and more. Investor Idea’s original branded content
includes podcasts and columns : Crypto Corner , Play
by Play sports and stock news , Investor Ideas Potcasts
Cannabis News and Stocks on the Move podcast ,
Cleantech
and Climate Change , Exploring
Mining , Betting
on Gaming Stocks Podcast and
the AI
Eye Podcast.
The Investorideas.com podcasts are also available on Apple Podcasts
, Audible , Spotify, Tunein, Stitcher,
Spreaker.com, iHeartRadio, Google Podcasts
and most audio platforms available.
Visit the Podcast
page at Investorideas.com: https://www.investorideas.com/Audio/
Disclaimer/Disclosure: Investorideas.com is a digital publisher of
third party sourced news, articles and equity research as well as creates
original content, including video, interviews and articles. Original content
created by investorideas is protected by copyright laws other than syndication
rights. Our site does not make recommendations for purchases or sale of stocks,
services or products. Nothing on our sites should be construed as an offer or
solicitation to buy or sell products or securities. All investing involves risk
and possible losses. This site is currently compensated for news publication
and distribution, social media and marketing, content creation and more.
Disclosure is posted for each compensated news release, content published
/created if required but otherwise the news was not compensated for and was
published for the sole interest of our readers and followers. Contact
management and IR of each company directly regarding specific questions. More
disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about
publishing your news release and our other news services on the
Investorideas.com newswire https://www.investorideas.com/News-Upload/ Global investors must
adhere to regulations of each country. Please read Investorideas.com privacy
policy: https://www.investorideas.com/About/Private_Policy.asp
The AI Eye-
Watching stock news, deal tracker and advancements in artificial
intelligence is an original content brand of Investorideas.com
Follow us on Twitter https://twitter.com/Investorideas
Follow us on Facebook https://www.facebook.com/Investorideas
Follow us on YouTube https://www.youtube.com/c/Investorideas
Contact
Investorideas.com
800 665 0411
Get more Technology stock investor
ideas - news, articles, podcasts and stock directories
No comments:
Post a Comment